|
Sitaraman, S; Metzger, D W; Belloto, R J et al. (2000) Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice. J Neuroimmunol 107:73-82
|
|
Infante, A J; Kraig, E (1999) Myasthenia gravis and its animal model: T cell receptor expression in an antibody mediated autoimmune disease. Int Rev Immunol 18:83-109
|
|
Stone, W H; Brunn, D A; Foster, E B et al. (1998) Absence of a significant mixed lymphocyte reaction in a marsupial (Monodelphis domestica). Lab Anim Sci 48:184-9
|
|
Kraig, E; Pierce, J L; Clarkin, K Z et al. (1996) Restricted T cell receptor repertoire for acetylcholine receptor in murine myasthenia gravis. J Neuroimmunol 71:87-95
|
|
Pierce, J L; Zborowski, K A; Kraig, E et al. (1994) Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis. Int Immunol 6:775-83
|
|
Thompson, P A; McAtee, R; Infante, A J et al. (1994) V beta-specific immunotoxin selectively kills acetylcholine receptor-reactive T lymphocytes from mice with experimental autoimmune myasthenia gravis. Int Immunol 6:1807-15
|
|
Wall, K A; Hu, J Y; Currier, P et al. (1994) A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. J Immunol 152:4526-36
|
|
Infante, A J; Levcovitz, H; Gordon, V et al. (1992) Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice. J Immunol 148:3385-90
|
